Abstract
ObjectiveTo examine the long-term changes in circulating B cell subsets and IgG levels at 5+ years of continuous belimumab treatment and their correlations with efficacy and safety measures.MethodsThis was a...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have